Employer-based insurance coverage increases utilization of planned oocyte cryopreservation

Yeshua, Arielle; Abittan, Baruch; Bar-El, Liron; Mullin, Christine; Goldman, Randi H.

doi:10.1007/s10815-022-02506-z

Cited by 6 publications

(4 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Mercer's National Survey of Employer-Sponsored Health Plans in 2022 showed a steady increase in the number of employers offering fertility and OC benefits: up to 21% of survey respondents in 2021 [42]. Data also demonstrate that employees are more likely to pursue fertility preservation if a company benefit is available [43,44]. Multiple studies purport that insurance coverage alone cannot eliminate racial and ethnic disparities in ART usage.…”

Section: Role Of Insurance In Reducing Disparitiesmentioning

confidence: 99%

Racial Disparities in Fertility Care: A Narrative Review of Challenges in the Utilization of Fertility Preservation and ART in Minority Populations

Gadson,

Sauerbrun-Cutler,

Eaton

2024

JCM

View full text Add to dashboard Cite

Significant ethnic and racial disparities exist in the utilization and outcomes of assisted reproductive technology (ART) in the United States. The popularity of fertility preservation (FP) procedures, a specific application of ART for those desiring to delay childbearing, has increased; however, many minority populations have seen a less rapid uptake of these services. Minority patients pursuing ART are more likely to have poorer in vitro fertilization (IVF) and pregnancy outcomes. These outcomes are used to predict success after FP and may lessen the appeal of such procedures in these populations. Suboptimal outcomes are further compounded by challenges with receiving referrals to, accessing, and paying for FP services. Resolving these disparities in minority populations will require culturally appropriate education surrounding the benefits of ART and FP, the demonstration of favorable outcomes in ART and FP through continued research engaging minority participants, and continued advocacy for expanded access to care for patients.

show abstract

Section: Role Of Insurance In Reducing Disparitiesmentioning

confidence: 99%

Racial Disparities in Fertility Care: A Narrative Review of Challenges in the Utilization of Fertility Preservation and ART in Minority Populations

Gadson,

Sauerbrun-Cutler,

Eaton

2024

JCM

View full text Add to dashboard Cite

show abstract

“…The utilization of FP or infertility treatment have been shown to increase when employers offer benefits or states mandate infertility insurance coverage. For example, when a hospital employerbased insurance started covering planned oocyte cryopreservation, the hospital-based fertility center saw a 79% increase in insured patients freezing oocytes, and the number of overall patients with hospital-based insurance coverage that underwent planned oocyte cryopreservation increased by a factor of 8 (5.3 to 41.5%, p < 0.001) [31]. Although the indications are different, we similarly expect a steep increase in medical FP utilization as coverage increases when more medical FP insurance mandates are passed.…”

Section: Utilization Increases With Infertility Insurance Mandates Or...mentioning

confidence: 99%

The Status of Fertility Preservation (FP) Insurance Mandates and Their Impact on Utilization and Access to Care

Sauerbrun-Cutler,

Rollo,

Gadson

et al. 2024

JCM

View full text Add to dashboard Cite

Fertility preservation (FP) is the use of a specific medical intervention to protect the fertility of individuals whose disease or disease treatment may lead to infertility. These medical interventions include the cryopreservation of oocytes, embryos, ovarian tissue, sperm, and testicular tissue; oocyte and embryo cryopreservation are the most widely used interventions in the United States. Although guidelines recommend FP prior to undergoing gonadotoxic treatments, cost barriers are high. For example, the average cost of an oocyte cryopreservation cycle in the United States exceeds $10,000. High cost and lack of insurance coverage are two of the most cited reasons explaining the low Reproductive Endocrinology and Infertility (REI) referral rates and limited FP utilization. Broadening insurance mandates for FP prior to gonadotoxic treatments could improve utilization and provide cancer survivors with improved quality of life post treatment.

show abstract

“…For companies with 500 or more employees, only 11% offered coverage for planned OC in 2020 [123]. Studies have shown that more comprehensive insurance coverage increases patient willingness to consider planned OC and results in increased utilization [8,124]. Cardozo et al (2020) found that 81% of surveyed graduate students would be more likely to consider planned OC if it were covered by insurance or paid for by their employer.…”

Section: Financial Considerationsmentioning

confidence: 99%

Oocyte Cryopreservation for Medical and Planned Indications: A Practical Guide and Overview

Han

Seifer

2023

JCM

View full text Add to dashboard Cite

Oocyte cryopreservation (OC) is the process in which ovarian follicles are stimulated, the follicular fluid is retrieved, and mature oocytes are isolated and vitrified. Since the first successful pregnancy utilizing previously cryopreserved oocytes in 1986, OC has become increasingly utilized as an option for future biologic children in patients facing gonadotoxic therapies, such as for the treatment of cancer. Planned OC, also termed elective OC, is growing in popularity as a means to circumvent age-related fertility decline. In this narrative review, we describe both medically indicated and planned OC, focusing on the physiology of ovarian follicular loss, OC technique and risks, timing of when OC should be performed, associated financial considerations, and outcomes.

show abstract

Employer-based insurance coverage increases utilization of planned oocyte cryopreservation

Cited by 6 publications

References 19 publications

Racial Disparities in Fertility Care: A Narrative Review of Challenges in the Utilization of Fertility Preservation and ART in Minority Populations

Racial Disparities in Fertility Care: A Narrative Review of Challenges in the Utilization of Fertility Preservation and ART in Minority Populations

The Status of Fertility Preservation (FP) Insurance Mandates and Their Impact on Utilization and Access to Care

Oocyte Cryopreservation for Medical and Planned Indications: A Practical Guide and Overview

Contact Info

Product

Resources

About